In this study, we examined the bioactivity of the two synthetic peptides CM-1 and CM-2 on human foreskin fibroblasts (HFF)
The weight-loss medication carries a significantly elevated risk of non-arteritic anterior ischemic optic neuropathy (NAION) compared to Ozempic due to higher prescribed doses, affecting approximately 8.7 per million prescriptions
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
Severity and combination of symptoms can vary widely between individuals, and may also fluctuate over the course of treatment
The Medicare GLP-1 Bridge is a CMS program covering obesity-indicated drugs like Wegovy through a dedicated central processor
This is why anyone considering, using or prescribing GLP-1 medication should pair it with: Progressive resistance training (Jensen 2024) High-quality protein at each meal (Phillips & Paddon-Jones 2023) Lower-glycaemic, minimally processed foods (Ludwig & Ebbeling 2022) Adequate sleep and stress management (Walker 2020) These behaviours protect muscle, bone, metabolic rate and long-term health things the medication cannot do on its own
